121 related articles for article (PubMed ID: 16613343)
1. Coexistent anaplastic and differentiated thyroid carcinoma: an immunohistochemical study.
Aratake Y; Nomura H; Kotani T; Marutsuka K; Kobayashi K; Kuma K; Miyauchi A; Okayama A; Tamura K
Am J Clin Pathol; 2006 Mar; 125(3):399-406. PubMed ID: 16613343
[TBL] [Abstract][Full Text] [Related]
2. Coexistent Anaplastic and Differentiated Thyroid Carcinoma.
Aratake Y; Nomura H; Kotani T; Marutsuka K; Kobayashi K; Kuma K; Miyauchi A; Okayama A; Okayama A
Am J Clin Pathol; 2006 Mar; 125(3):399-406. PubMed ID: 16613808
[TBL] [Abstract][Full Text] [Related]
3. Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions.
Albores-Saavedra J; Hernandez M; Sanchez-Sosa S; Simpson K; Angeles A; Henson DE
Am J Surg Pathol; 2007 May; 31(5):729-36. PubMed ID: 17460457
[TBL] [Abstract][Full Text] [Related]
4. Derangement of the E-cadherin/catenin complex is involved in transformation of differentiated to anaplastic thyroid carcinoma.
Wiseman SM; Masoudi H; Niblock P; Turbin D; Rajput A; Hay J; Filipenko D; Huntsman D; Gilks B
Am J Surg; 2006 May; 191(5):581-7. PubMed ID: 16647341
[TBL] [Abstract][Full Text] [Related]
5. [Anaplastic carcinoma of the thyroid].
Brocheriou C
Arch Anat Cytol Pathol; 1998; 46(1-2):87-93. PubMed ID: 9754363
[TBL] [Abstract][Full Text] [Related]
6. Diffuse (or multinodular) follicular variant of papillary thyroid carcinoma: a clinicopathologic and immunohistochemical analysis of ten cases of an aggressive form of differentiated thyroid carcinoma.
Ivanova R; Soares P; Castro P; Sobrinho-Simões M
Virchows Arch; 2002 Apr; 440(4):418-24. PubMed ID: 11956824
[TBL] [Abstract][Full Text] [Related]
7. Differences in tumor cell proliferation, HLA DR expression and lymphocytic infiltration in various types of thyroid carcinoma.
Lindhorst E; Schumm-Draeger PM; Bojunga J; Usadel KH; Herrmann G
Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):27-31. PubMed ID: 11835122
[TBL] [Abstract][Full Text] [Related]
8. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
9. Genetic mutations in thyroid carcinoma.
Taccaliti A; Boscaro M
Minerva Endocrinol; 2009 Mar; 34(1):11-28. PubMed ID: 19209125
[TBL] [Abstract][Full Text] [Related]
10. Inverse relationships between the expression of MMP-7 and MMP-11 and predictors of poor prognosis of papillary thyroid carcinoma.
Ito Y; Yoshida H; Kakudo K; Nakamura Y; Kuma K; Miyauchi A
Pathology; 2006 Oct; 38(5):421-5. PubMed ID: 17008280
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic evaluation of immunohistochemical CD147 and MMP-2 expression in differentiated thyroid carcinoma.
Tan H; Ye K; Wang Z; Tang H
Jpn J Clin Oncol; 2008 Aug; 38(8):528-33. PubMed ID: 18664479
[TBL] [Abstract][Full Text] [Related]
12. [Malignant transformation of thyroid cancer; poorly differentiated cancer and anaplastic cancer transformation].
Kasai N; Sakamoto A
Gan No Rinsho; 1983 Feb; 29(2):A-7, 105-10. PubMed ID: 6876397
[TBL] [Abstract][Full Text] [Related]
13. The anaplastic transformation of differentiated thyroid carcinoma. An ultrastructural study.
Dumitriu L; Stefăneanu L; Taşcă C
Endocrinologie; 1984; 22(2):91-6. PubMed ID: 6740202
[TBL] [Abstract][Full Text] [Related]
14. [C-cells in malignant epithelial tumors of the thyroid gland].
Derizhanova IS; Sidorenko SI
Vopr Onkol; 1998; 44(6):686-90. PubMed ID: 10087965
[TBL] [Abstract][Full Text] [Related]
15. [Problem areas of tumour classifications--thyroid carcinomas].
Schmid KW
Verh Dtsch Ges Pathol; 2007; 91():57-65. PubMed ID: 18314596
[TBL] [Abstract][Full Text] [Related]
16. CD147 expression as a significant prognostic factor in differentiated thyroid carcinoma.
Tan H; Ye K; Wang Z; Tang H
Transl Res; 2008 Sep; 152(3):143-9. PubMed ID: 18774544
[TBL] [Abstract][Full Text] [Related]
17. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
18. Prognostic indicators in differentiated thyroid carcinoma.
Dean DS; Hay ID
Cancer Control; 2000; 7(3):229-39. PubMed ID: 10832109
[TBL] [Abstract][Full Text] [Related]
19. Expression and mutation analysis of the tyrosine kinase c-kit in poorly differentiated and anaplastic thyroid carcinoma.
Broecker-Preuss M; Sheu SY; Worm K; Feldkamp J; Witte J; Scherbaum WA; Mann K; Schmid KW; Schott M
Horm Metab Res; 2008 Oct; 40(10):685-91. PubMed ID: 18622894
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical staining for thyroglobulin in poorly differentiated carcinoma of the thyroid.
Ratnatnga N; Ramadasa S
Ceylon Med J; 1993 Sep; 38(3):113-6. PubMed ID: 7828228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
